Cough, Cold and Allergy (Hay Fever) Remedies in Japan

October 2026

In 2026, cough, cold and allergy (hay fever) remedies in Japan is set to demonstrated modest value growth of 2% to JPY298 billion, lagging the stronger post-pandemic rebound observed elsewhere in Asia Pacific due to a pronounced focus on prevention and early intervention over symptomatic relief. The environment remains attractive for companies able to deliver premium, clinically credible products, as consumer demand shifts towards allergy management driven by prolonged pollen seasons and regulatory changes that incentivise self-medication. With the top five players retaining a combined share above 35% and new strategic alliances, such as the integration of Suntory Holdings and Daiichi Sankyo Healthcare, the landscape rewards brands that can innovate in prescription-inspired formulations and invest in trust-building through regulatory alignment and pharmacist guidance. As population decline and restrained economic growth persist, companies must pursue value through product differentiation, omnichannel strategies and education-led engagement to succeed in a maturing market.

USD 1,195
Request More Information

Delivery:

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

This report comes in PDF with additional info in Excel included.

Overview:

Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Japan with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.

Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Japan, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.

The Cough, Cold and Allergy (Hay Fever) Remedies in Japan report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volume and value sizes, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent research methodology, conducted in-country

This report answers:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Japan?
  • Which are the leading brands in Cough, Cold and Allergy (Hay Fever) Remedies in Japan?
  • How are products distributed in Cough, Cold and Allergy (Hay Fever) Remedies in Japan?
  • How has the regulatory and operating environment for Cough, Cold and Allergy (Hay Fever) Remedies changed in Japan?
  • How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Cough, Cold and Allergy (Hay Fever) Remedies
  • How significant are wider health concerns and consumer awareness in determining sales?
  • Where is future growth expected to be most dynamic?

Key Data Insights

Key Industry Trends

Value sales experience modest growth
Antihistamines surge as pollen season drives demand for prevention
Daiichi Sankyo Healthcare builds trust with premium products
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Allergy remedy makers accelerate premium launches
Antihistamines maintain lead as allergy seasons lengthen
Premiumisation and self-care reshape growth and competition
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Suntory’s acquisition of Daiichi Sankyo Healthcare sparks self-medication race
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Health and beauty specialists build trust and guide consumers
E-commerce drives repeat purchases with convenience
Chart 1 Retail Channels 2021-2026
Manufacturers boost premium launches to capture allergy demand
Prescription-inspired launches drive value and reshape competition
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031

Country Reports Disclaimer

The following categories and subcategories are included:

Cough, Cold and Allergy (Hay Fever) Remedies

  • Antihistamines/Allergy Remedies (Systemic)
    • Paediatric Allergy Remedies
    • Paediatric Cough/Cold Remedies
  • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
  • Cough Remedies
    • Nasal Sprays
    • Oral Decongestants
    • Inhalant Decongestants
    • Decongestant Rubs
    • Nasal Decongestant Drops
    • Nasal Decongestant Plasters
  • Medicated Confectionery
  • Pharyngeal Preparations

Cough, Cold and Allergy (Hay Fever) Remedies

This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.

See all of our definitions
Share:

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!